These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35129466)

  • 21. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
    Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
    Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
    Peixoto RD; Lim HJ; Kim H; Abdullah A; Cheung WY
    J Gastrointest Cancer; 2014 Sep; 45(3):325-33. PubMed ID: 24756830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
    Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
    Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis.
    Lee Y; Samarasinghe Y; Lee MH; Thiru L; Shargall Y; Finley C; Hanna W; Levine O; Juergens R; Agzarian J
    Ann Surg; 2022 Jan; 275(1):91-98. PubMed ID: 34596073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent Disease After Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study.
    Kalff MC; Henckens SPG; Voeten DM; Heineman DJ; Hulshof MCCM; van Laarhoven HWM; Eshuis WJ; Baas PC; Bahadoer RR; Belt EJT; Brattinga B; Claassen L; Ćosović A; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; Drost M; van Duijvendijk P; van Esser S; Gaspersz MP; Görgec B; Groenendijk RPR; Hartgrink HH; van der Harst E; Haveman JW; Heisterkamp J; van Hillegersberg R; Kelder W; Kingma BF; Koemans WJ; Kouwenhoven EA; Lagarde SM; Lecot F; van der Linden PP; Luyer MDP; Nieuwenhuijzen GAP; Olthof PB; van der Peet DL; Pierie JEN; Pierik EGJMR; Plat VD; Polat F; Rosman C; Ruurda JP; van Sandick JW; Scheer R; Slootmans CAM; Sosef MN; Sosef OV; de Steur WO; Stockmann HBAC; Stoop FJ; Vugts G; Vijgen GHEJ; Weeda VB; Wiezer MJ; van Oijen MGH; van Berge Henegouwen MI; Gisbertz SS
    Ann Surg; 2022 Nov; 276(5):806-813. PubMed ID: 35880759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study.
    Markar SR; Noordman BJ; Mackenzie H; Findlay JM; Boshier PR; Ni M; Steyerberg EW; van der Gaast A; Hulshof MCCM; Maynard N; van Berge Henegouwen MI; Wijnhoven BPL; Reynolds JV; Van Lanschot JJB; Hanna GB
    Ann Oncol; 2017 Mar; 28(3):519-527. PubMed ID: 28039180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus and gastroesophageal junction: a multicenter retrospective observational study of young versus old patients.
    Rompen IF; Crnovrsanin N; Nienhüser H; Neuschütz K; Fourie L; Sisic L; Müller-Stich BP; Billeter AT
    Int J Surg; 2023 Dec; 109(12):3804-3814. PubMed ID: 37720939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.
    Mantziari S; Gronnier C; Renaud F; Duhamel A; Théreaux J; Brigand C; Carrère N; Lefevre JH; Pasquer A; Demartines N; Collet D; Meunier B; Mariette C;
    Ann Surg; 2017 Nov; 266(5):805-813. PubMed ID: 28742698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
    Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
    BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.
    Sisic L; Strowitzki MJ; Blank S; Nienhueser H; Dorr S; Haag GM; Jäger D; Ott K; Büchler MW; Ulrich A; Schmidt T
    Gastric Cancer; 2018 May; 21(3):552-568. PubMed ID: 28741059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction.
    Faron M; Cheugoua-Zanetsie AM; Thirion P; Nankivell M; Winter K; Cunningham D; Van der Gaast A; Law S; Langley R; de Vathaire F; Valmasoni M; Mauer M; Roth J; Gebski V; Burmeister BH; Paoletti X; van Sandick J; Fu J; Ducreux M; Blanchard P; Tierney J; Pignon JP; Michiels S;
    Eur J Cancer; 2021 Nov; 157():278-290. PubMed ID: 34555647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients with esophageal cancer.
    Kidane B; Sulman J; Xu W; Kong QQ; Wong R; Knox JJ; Darling GE
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1571-80. PubMed ID: 27016795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved treatment decisions in patients with esophageal cancer.
    Amdal CD; Jacobsen AB; Falk RS; Johnson E; Os SS; Warloe T; Bjordal K
    Acta Oncol; 2017 Oct; 56(10):1286-1294. PubMed ID: 28686501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.